A. BROSSI

3.0k total citations
139 papers, 2.0k citations indexed

About

A. BROSSI is a scholar working on Organic Chemistry, Molecular Biology and Cancer Research. According to data from OpenAlex, A. BROSSI has authored 139 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Organic Chemistry, 41 papers in Molecular Biology and 18 papers in Cancer Research. Recurrent topics in A. BROSSI's work include Chemical synthesis and alkaloids (33 papers), Synthesis and Biological Activity (16 papers) and Asymmetric Synthesis and Catalysis (15 papers). A. BROSSI is often cited by papers focused on Chemical synthesis and alkaloids (33 papers), Synthesis and Biological Activity (16 papers) and Asymmetric Synthesis and Catalysis (15 papers). A. BROSSI collaborates with scholars based in United States, Switzerland and Brazil. A. BROSSI's co-authors include S. Teitel, H. Bruderer, O. Schnider, Milan R. Uskoković, J.L. Flippen-Anderson, Kenner C. Rice, Wilbur K. Milhous, Xun Luo, Pierre‐Alain Buchs and B. Venugopalan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

A. BROSSI

134 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. BROSSI United States	23	954	639	297	277	265	139	2.0k
Jörg Holenz Germany	24	830 0.9×	615 1.0×	154 0.5×	249 0.9×	155 0.6×	43	1.4k
Pierre Crabbé France	24	1.4k 1.5×	764 1.2×	220 0.7×	61 0.2×	97 0.4×	142	2.3k
Matthew J. Wyvratt United States	34	1.5k 1.5×	1.6k 2.5×	218 0.7×	266 1.0×	72 0.3×	116	3.9k
Joaquín M. Campos Rosa Spain	33	1.3k 1.4×	1.6k 2.6×	384 1.3×	167 0.6×	113 0.4×	164	3.5k
Philippe Chavatte France	26	707 0.7×	1.2k 1.8×	504 1.7×	280 1.0×	95 0.4×	85	2.5k
J. J. Ghosh India	23	168 0.2×	890 1.4×	600 2.0×	174 0.6×	105 0.4×	120	2.2k
Doris Feineis Germany	23	801 0.8×	510 0.8×	181 0.6×	192 0.7×	130 0.5×	83	1.4k
Martin E. Kuehne United States	35	2.3k 2.4×	985 1.5×	233 0.8×	588 2.1×	1.1k 4.0×	106	3.3k
Jukka Gynther Finland	27	351 0.4×	650 1.0×	171 0.6×	339 1.2×	267 1.0×	73	1.7k
Angeliki P. Kourounakis Greece	29	852 0.9×	894 1.4×	303 1.0×	173 0.6×	194 0.7×	69	2.1k

Countries citing papers authored by A. BROSSI

Since Specialization

Citations

This map shows the geographic impact of A. BROSSI's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. BROSSI with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. BROSSI more than expected).

Fields of papers citing papers by A. BROSSI

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. BROSSI. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. BROSSI. The network helps show where A. BROSSI may publish in the future.

Co-authorship network of co-authors of A. BROSSI

This figure shows the co-authorship network connecting the top 25 collaborators of A. BROSSI. A scholar is included among the top collaborators of A. BROSSI based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. BROSSI. A. BROSSI is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

BROSSI, A., et al.. (2023). Compreendendo os efeitos farmacológicos dos benzodiazepínicos e o impacto negativo na memória. 4(1).

Kopsombut, Prapaporn, et al.. (1993). Effects of mescaline and some of its analogs on cholinergic neuromuscular transmission. Neuropharmacology. 32(2). 169–174. 17 indexed citations

Atack, John, et al.. (1989). Comparative inhibitory effects of various physostigmine analogs against acetyl- and butyrylcholinesterases.. Journal of Pharmacology and Experimental Therapeutics. 249(1). 194–202. 81 indexed citations

Kawabuchi, Masaru, et al.. (1988). Enantiomer (+)physostigmine prevents organophosphate‐induced subjunctional damage at the neuromuscular synapse by a mechanism not related to cholinesterase carbamylation. Synapse. 2(2). 139–147. 22 indexed citations

Aracava, Yasco, et al.. (1987). The Molecular Basis of Anticholinesterase Actions on Nicotinic and Glutamatergic Synapses^a. Annals of the New York Academy of Sciences. 505(1). 226–255. 20 indexed citations

Abell, Creed W., Rong Shen, Wieslaw Gessner, & A. BROSSI. (1986). Comparative studies of the release of 1-methyl-4-phenyl-pyridinium species (MPP/sup +/) from rat and mouse brain synaptosomes. Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States). 1 indexed citations

Bhattacharyya, B., et al.. (1986). B ring regulation of colchicine binding kinetics and fluorescence.. Proceedings of the National Academy of Sciences. 83(7). 2052–2055. 51 indexed citations

BROSSI, A., et al.. (1986). Inhibition of acetylcholinesterase from electric eel by (−)‐ and (+)‐physostigmine and related compounds. FEBS Letters. 201(2). 190–192. 24 indexed citations

Abell, Creed W., et al.. (1985). Serotonergic conversion of MPTP and dopaminergic accumulation of MPP⁺. FEBS Letters. 189(2). 225–230. 31 indexed citations

10.

Maleque, M A, et al.. (1984). Interaction of analogs of histrionicotoxin with the acetylcholine receptor ionic channel complex and membrane excitability.. Journal of Pharmacology and Experimental Therapeutics. 229(1). 72–79. 4 indexed citations

11.

Rahman, M. F. & A. BROSSI. (1977). ChemInform Abstract: PREPARATION AND ANALGESIC ACTIVITY OF SOME 3,4‐DISUBSTITUTED N‐METHYLMORPHINANS OF THE (‐) SERIES. Chemischer Informationsdienst. 8(47). 2 indexed citations

12.

BROSSI, A., et al.. (1971). Darstellung und Eigenschaften von 1,2,3,4,5,6‐Hexahydro‐8‐hydroxy‐3‐methyl‐3‐benzazocin. Helvetica Chimica Acta. 54(2). 743–748. 4 indexed citations

13.

BROSSI, A., et al.. (1970). Synthesis of 7‐Methoxy‐1,2,3,4‐tetrahydro‐5‐isoquinolinol. Journal of Heterocyclic Chemistry. 7(6). 1401–1402.

14.

BROSSI, A., et al.. (1965). Syntheses of various 2,5‐disubstituted oxazole derivatives related to natural products. Journal of Heterocyclic Chemistry. 2(3). 310–312. 5 indexed citations

15.

BROSSI, A., F. Schenker, & W. Leimgruber. (1964). Synthesen in der Isochinolinreihe Neue Synthesen der Kaktusalkaloide Anhalamin, Anhalidin, rac. Anhalonidin und rac. Pellotin. Helvetica Chimica Acta. 47(7). 2089–2098. 21 indexed citations

16.

BROSSI, A., et al.. (1960). Synthesen in der Isochinolinreihe Halogensubstituierte 1‐(ω‐Phenylalkyl)‐1,2,3,4‐tetrahydro‐isochinoline als Analgetica. Helvetica Chimica Acta. 43(6). 1459–1472. 27 indexed citations

17.

BROSSI, A., J. Würsch, & O. Schnider. (1958). Syntheseversuche in der Emetin-Reihe. CHIMIA International Journal for Chemistry. 12(4). 114–114. 3 indexed citations

18.

Häfliger, O., A. BROSSI, L. H. Chopard‐dit‐Jean, Michael G. Walter, & O. Schnider. (1956). Hydroxy‐Morphinane. Mitteilung. Über ein Photooxydationsprodukt von (+)‐3‐Methoxy‐N‐methyl‐morphinan. Helvetica Chimica Acta. 39(7). 2053–2062. 11 indexed citations

19.

BROSSI, A. & O. Schnider. (1956). Hydroxy‐Morphinane. 9. Mitteilung. Versuche zur Racemisierung optisch aktiver 1‐(p‐Hydroxybenzyl)‐1,2,3,4,5,6,7,8‐octahydro‐isochinoline. Helvetica Chimica Acta. 39(5). 1376–1386. 10 indexed citations

20.

Schnider, O., A. BROSSI, & K. Vogler. (1954). Oxy‐morphinane. 5. Mitteilung. Optisch aktive Benzyl‐octahydro‐isochinoline. Helvetica Chimica Acta. 37(3). 710–720. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact